Jubilant Pharmova
JUBLPHARMA.NS
#4820
Rank
โ‚น164.65 B
Marketcap
โ‚น1,040
Share price
-3.41%
Change (1 day)
-10.31%
Change (1 year)

Revenue for Jubilant Pharmova (JUBLPHARMA.NS)

Revenue in 2025 (TTM): โ‚น73.50 Billion

According to Jubilant Pharmova's latest financial reports the company's current revenue (TTM ) is โ‚น77.68 Billion. In 2024 the company made a revenue of โ‚น70.22 Billion an increase over the revenue in the year 2023 that were of โ‚น65.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Jubilant Pharmova from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น73.50 B4.67%
2024 โ‚น70.22 B7.07%
2023 โ‚น65.59 B8.01%
2022 โ‚น60.72 B-0.39%
2021 โ‚น60.96 B-9.27%
2020 โ‚น67.19 B-18.42%
2019 โ‚น82.36 B-7.13%
2018 โ‚น88.68 B31.06%
2017 โ‚น67.66 B17.72%
2016 โ‚น57.48 B0.73%
2015 โ‚น57.06 B-1.69%
2014 โ‚น58.04 B4.43%
2013 โ‚น55.58 B